{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:05:04Z","timestamp":1781100304697,"version":"3.54.1"},"reference-count":22,"publisher":"Informa UK Limited","issue":"18","funder":[{"name":"Abbott, Alter, Aptatargets, Chemo, FAES, Farmal\u00edder, Ferrer"},{"name":"Galenicum, GlaxoSmithKline, Gilead, Italfarmaco, Janssen-Cilag"},{"name":"Kern, Normon, Novartis, Servier, Teva and Zambon"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.2217\/pgs-2022-0161","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T10:12:18Z","timestamp":1669111938000},"page":"949-952","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Use of Pharmacogenetics for Benzodiazepine Prescription: State of the Art and Expectations"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6150-4320","authenticated-orcid":false,"given":"Pablo","family":"Zubiaur","sequence":"first","affiliation":[{"name":"Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Te\u00f3filo Hernando, Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Universidad Aut\u00f3noma de Madrid (UAM), Madrid, 28029, Spain"},{"name":"Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Research Institute, Kansas City, MO64108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6519-8885","authenticated-orcid":false,"given":"Francisco","family":"Abad-Santos","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Te\u00f3filo Hernando, Instituto de Investigaci\u00f3n Sanitaria La Princesa (IP), Universidad Aut\u00f3noma de Madrid (UAM), Madrid, 28029, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, 28200, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1021\/cn5000056"},{"key":"e_1_3_2_3_1","first-page":"133","article-title":"On the history of barbiturates","volume":"43","author":"Norn S","year":"2015","unstructured":"Norn S , PerminH, KruseE, KrusePR. On the history of barbiturates. Dan. Medicinhist. Arbog43, 133\u2013151 (2015).","journal-title":"Dan. Medicinhist. Arbog"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03563.x"},{"key":"e_1_3_2_5_1","volume-title":"StatPearls.","author":"Dhaliwal JS","year":"2022","unstructured":"Dhaliwal JS , RosaniA, SaadabadiA. Diazepam. In: StatPearls.StatPearls Publishing, FL, USA (2022). www.ncbi.nlm.nih.gov\/books\/NBK537022\/"},{"key":"e_1_3_2_6_1","unstructured":"Amanda Lautieri . Valium History and Statistics. November 11 2022. https:\/\/drugabuse.com\/benzodiazepines\/valium\/history-and-statistics\/"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08984-z"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574886312666170109115741"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmt010"},{"issue":"1","key":"e_1_3_2_10_1","first-page":"90","article-title":"Side effects of treatment with benzodiazepines","volume":"22","author":"Uzun S","year":"2010","unstructured":"Uzun S , KozumplikO, Jakovljevi\u0107M, Sedi\u0107B. Side effects of treatment with benzodiazepines. Psychiatr. Danub.22(1), 90\u201393 (2010).","journal-title":"Psychiatr. Danub."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02124.x"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2022.05.001"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.08.020"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113747"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0018578720931756"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1773-z"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0145"},{"issue":"4","key":"e_1_3_2_18_1","first-page":"460","article-title":"Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4","volume":"29","author":"Kilicarslan T","year":"2001","unstructured":"Kilicarslan T , HainingRL, RettieAE, BustoU, TyndaleRF, SellersEM. Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4. Drug Metab. Dispos.29(4 Pt 1), 460\u2013465 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-003-0681-4"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.051656"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201800321"},{"key":"e_1_3_2_22_1","unstructured":"Spanish Drug Agency . Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a. (2022). www.aemps.gob.es\/medicamentos-de-uso-humano\/observatorio-de-uso-de-medicamentos\/informes-ansioliticos-hipnoticos\/?lang=en"},{"key":"e_1_3_2_23_1","unstructured":"Spanish Drug Agency . Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a durante el periodo 2000\u20132012. (2014). www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/ansioliticos_hipnoticos-2000-2012.pdf"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2022-0161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:54:22Z","timestamp":1715957662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2022-0161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":22,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.2217\/pgs-2022-0161"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2022-0161","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}